Nephrologists will receive boosts in payments – especially in the rate for reimbursement for home dialysis – starting on January 1, 2021, according a final rule recently issued by the Centers for Medicare and Medicaid Services (CMS). The increases to nephrologists’ reimbursements were part of a multi-year push by ASN to increase the values incorporated in those reimbursement calculations.
In September 2020, the Centers for Medicare & Medicaid Services (CMS) and its Innovation Center (CMMI) finalized the End-Stage Renal Disease (ESRD) Treatment Choices (ETC) Model. This mandatory payment model will test changes to care for Americans with kidney disease within a 30%, randomized set of Medicare beneficiaries with kidney failure.
The stated goals are increasing patient choice, increasing utilization of home dialysis, and providing greater access to transplantation, options for which the American Society of Nephrology (ASN) has long advocated.
The American Society of Nephrology (ASN) commends the Centers for Medicare and Medicaid Services (CMS) and its Innovation Center (CMMI) for finalizing the End-Stage Renal Disease (ESRD) Treatment Choices (ETC) Model today. This model will herald positive changes to care for the more than 37 million Americans with kidney diseases, including more patient choice, increased utilization of home dialysis, and greater access to transplantation, options for which ASN has long advocated.
Changes ASN has long pushed for will be implemented.
Nephrologists will receive a boost in payments – especially in the rate for reimbursement for home dialysis – made to them by the Centers for Medicare and Medicaid Services (CMS). ASN is proud to have played a significant role by pushing for this change that will begin January 1, 2021. This move is long overdue and reflects the priority placed on kidney care by the Executive Order on Advancing American Kidney Health of July 2019 and its focus on increasing rates of home dialysis.
Reducing the benchmark for the combined home dialysis and transplant rate and allowing for incremental achievement of the benchmark, incentivizing and investing wisely to ensure needed practice transformation, and delaying the start date of the ESRD Treatment Choice Model (ETC) until April 2020 are among the recommendations for adjustments to the model set forth in a letter sent to CMS Administrator Seema Verma on behalf of ASN and its members from President Mark E. Rosenberg, MD, FASN.